Stay updated on FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial
Sign up to get notified when there's something new on the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page.

Latest updates to the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has undergone significant updates regarding the clinical trial for FG-4592, including a clearer distinction between the Phase 2 and Phase 3 components, and the removal of specific details about the study's objectives and inclusion/exclusion criteria.SummaryDifference13%
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check93 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check101 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-4592 Efficacy/Safety in MDS Anemia Clinical Trial page.